Sionna Therapeutics, Inc. (SION)
3.34
-0.09
(-2.62%)
USD |
NASDAQ |
Nov 13, 16:00
3.34
0.00 (0.00%)
After-Hours: 19:59
Sionna Therapeutics Enterprise Value : -61.75M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | -61.75M |
| November 11, 2026 | -49.54M |
| November 10, 2026 | -49.54M |
| November 09, 2026 | -55.42M |
| November 06, 2026 | -68.53M |
| November 05, 2026 | -68.53M |
| November 04, 2026 | -48.19M |
| November 03, 2026 | -51.80M |
| November 02, 2026 | -48.19M |
| October 30, 2026 | -41.86M |
| October 29, 2026 | -35.98M |
| October 28, 2026 | -34.17M |
| October 27, 2026 | -41.86M |
| October 26, 2026 | -49.99M |
| October 23, 2026 | -54.06M |
| October 22, 2026 | -45.02M |
| October 21, 2026 | -41.86M |
| October 20, 2026 | -29.20M |
| October 19, 2026 | -35.53M |
| October 16, 2026 | -40.95M |
| October 15, 2026 | -32.36M |
| October 14, 2026 | -31.91M |
| October 13, 2026 | -18.80M |
| October 12, 2026 | -4.780M |
| October 09, 2026 | 4.715M |
| Date | Value |
|---|---|
| October 08, 2026 | 4.715M |
| October 07, 2026 | 1.097M |
| October 06, 2026 | -2.068M |
| October 05, 2026 | 2.454M |
| October 02, 2026 | 5.167M |
| October 01, 2026 | 13.76M |
| September 30, 2026 | 20.99M |
| September 29, 2026 | 29.63M |
| September 28, 2026 | 28.28M |
| September 25, 2026 | 33.25M |
| September 24, 2026 | 33.25M |
| September 23, 2026 | 45.89M |
| September 22, 2026 | 68.93M |
| September 21, 2026 | 68.02M |
| September 18, 2026 | 66.22M |
| September 17, 2026 | 121.32M |
| September 16, 2026 | 114.99M |
| September 15, 2026 | 107.77M |
| September 14, 2026 | 170.09M |
| September 11, 2026 | 151.58M |
| September 10, 2026 | 141.19M |
| September 09, 2026 | 134.87M |
| September 08, 2026 | 126.74M |
| September 04, 2026 | 121.32M |
| September 03, 2026 | 101.90M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 137.73B |
| Capricor Therapeutics, Inc. | 489.99M |
| ARS Pharmaceuticals, Inc. | 365.40M |
| ACADIA Pharmaceuticals, Inc. | 2.230B |
| Immunic, Inc. | -48.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.42M |
| Total Expenses (Quarterly) | 32.42M |
| EPS Diluted (Quarterly) | -0.7171 |
| Earnings Yield | -72.76% |
| Normalized Earnings Yield | -69.88 |